JD Orgochem Limited
Bombay Stock ExchangeTotal Valuation
JD Orgochem Limited carries a market capitalization of 215.84M, placing it among publicly traded companies globally. Its enterprise value stands at 919.01M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 215.84M |
| Enterprise Value | 919.01M |
Valuation Ratios
JD Orgochem Limited trades at a trailing price-to-earnings ratio of 5.94.
| PE Ratio | 5.94 |
| PS Ratio | 0.35 |
| PB Ratio | N/A |
| P/TBV Ratio | N/A |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
Enterprise Valuation
On an enterprise value basis, JD Orgochem Limited trades at an EV/EBITDA multiple of 4.93 and an EV/FCF ratio of 148.47. The EV/Sales ratio of 0.35 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 4.93 provides insight into valuation relative to core operating earnings.
| EV / Sales | 0.35 |
| EV / EBITDA | 4.93 |
| EV / EBIT | 4.93 |
| EV / FCF | 148.47 |
Financial Position
JD Orgochem Limited maintains a current ratio of 5.00, meaning it holds 5.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -67.03, indicating conservative leverage, while an interest coverage ratio of 21.68 demonstrates strong ability to service its debt obligations.
| Current Ratio | 5.00 |
| Quick Ratio | 1.44 |
| Debt / Equity | -67.03 |
| Debt / EBITDA | N/A |
| Interest Coverage | 21.68 |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | N/A |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | 258.08 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Taxes
Over the trailing twelve months, JD Orgochem Limited has paid 60.10M in income taxes, reflecting an effective tax rate of 27.97.
| Income Tax | 60.10M |
| Effective Tax Rate | 27.97 |
Stock Price Statistics
JD Orgochem Limited's stock has gained approximately 171.04825% over the past 52 weeks. The 50-day moving average sits at 3.11, while the 200-day moving average is 3.02.
| Beta (5Y) | N/A |
| 52-Week Price Change | 171.04825% |
| 50-Day Moving Average | 3.11 |
| 200-Day Moving Average | 3.02 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, JD Orgochem Limited generated 2.62B in revenue and converted that into 154.75M in net income, yielding earnings per share of 2.83. EBITDA reached 186.29M, while operating income came in at 186.29M.
| Revenue | 2.62B |
| Gross Profit | 802.11M |
| Operating Income | 186.29M |
| Pretax Income | 214.86M |
| Net Income | 154.75M |
| EBITDA | 186.29M |
| EBIT | 186.29M |
| Earnings Per Share (EPS) | 2.83 |
Margins
JD Orgochem Limited operates with a gross margin of 30.60, reflecting its pricing power and cost economics. The operating margin of 7.11 and net profit margin of 5.90 provide insight into operational efficiency.
| Gross Margin | 30.60 |
| Operating Margin | 7.11 |
| Pretax Margin | 8.20 |
| Profit Margin | 5.90 |
| EBITDA Margin | 7.11 |
Scores
JD Orgochem Limited posts an Altman Z-Score of 10.57, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 10.57 |